Lantern Pharma (LTRN) Financial Statements

318 Followers

Lantern Pharma Financial Overview

Lantern Pharma's market cap is currently $15.98M. The company's EPS TTM is $-0.36; its P/E ratio is >-0.01; Lantern Pharma is scheduled to report earnings on March 30, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 0.00	$ 0.00	$ -174.84K	$ 0.00	$ 0.00
Operating Income	$ -17.98B	$ -22.22M	$ -17.88M	$ -14.43M	$ -12.59M
EBITDA	$ -17.98B	$ -22.20M	$ -15.79M	$ -14.42M	$ -12.58M
Net Income	$ -17.12B	$ -20.78M	$ -15.96M	$ -14.26M	$ -12.36M
Balance Sheet
Cash & Short-Term Investments	$ 10.12B	$ 24.01M	$ 41.30M	$ 55.20M	$ 70.73M
Total Assets	$ 11.04B	$ 25.57M	$ 43.65M	$ 58.84M	$ 73.95M
Total Debt	$ 78.54M	$ 243.66K	$ 234.47K	$ 52.89K	$ 204.95K
Net Debt	$ -4.34B	$ -7.27M	$ -21.70M	$ -37.15M	$ -51.32M
Total Liabilities	$ 4.50B	$ 4.38M	$ 2.74M	$ 2.80M	$ 2.38M
Stockholders' Equity	$ 6.53B	$ 21.19M	$ 40.91M	$ 56.04M	$ 71.57M
Cash Flow
Free Cash Flow	$ -15.68B	$ -17.83M	$ -14.37M	$ -12.80M	$ -10.61M
Operating Cash Flow	$ -15.68B	$ -17.81M	$ -14.35M	$ -12.77M	$ -10.59M
Investing Cash Flow	$ 11.06B	$ 3.37M	$ -930.21K	$ 179.27K	$ -19.53M
Financing Cash Flow	$ 1.50B	$ 66.71K	$ -500.00K	$ -2.18M	$ 63.42M

Currency in USD

Lantern Pharma Earnings and Revenue History

Income Statement >

Lantern Pharma Debt to Assets

Balance Sheet >

Lantern Pharma Cash Flow

Cash Flow >

Lantern Pharma Forecast EPS vs Actual EPS

Earnings >